A prospective study of alcoholism and the risk of Parkinson's disease

Journal of Neurology

Volumn 251, Issue SUPPL. 7, 2004, Pages

  Hernán, Miguel A ^a   Logroscino, Giancarlo ^a   García Rodríguez, Luis A ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Ctro Espanol de Metrologia   (Spain)

Author keywords

Alcoholism; Parkinson's disease; Prospective studies

Indexed keywords

ADULT; AGED; ALCOHOLISM; CASE CONTROL STUDY; CIGARETTE SMOKING; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ALCOHOLISM; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 8644246576     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-004-1705-4     Document Type: Conference Paper

References (23)

1. Hernan MA, Takkouche B, Caamaño-Isorna F, Gestal-Otero J (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52:276-284
2. Paulson GW, Dadmehr N (1991) Is there a premorbid personality typical for Parkinson's disease? Neurology 41 (Suppl 2):73-76
3. Menza M (2000) The personality associated with Parkinson's disease. Curr Psychiatry Rep 2:421-426
4. Hernán MA, Chen H, Schwarzschild MA, Ascherio A (2003) Alcohol consumption and the incidence of Parkinson's disease. Ann Neurol 54:170-175
5. García Rodríguez LA, Pérez Gutthann S (1998) Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 45:419-425
6. Jick H, Jick S, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302:766-768
7. Jick H, Terris BZ, Derby LE, Jick S (1992) Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiology and Drug Safety 1:347-349
8. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. (2003) Validity of the General Practice Research Database. Pharmacotherapy 23:686-689
9. Schrag A, Ben-Shlomo Y, Quinn N (2002) How valid is the clinical diagnosis of Parkinson's disease in the community? J Neurol Neurosurg Psychiatry 73:529-534
10. Litvan I (1998) Parkinsonian features: when are they Parkinson disease? J Am Med Assoc 280:1654-1655
11. Bower J, Maraganore D, McDonnell S, Rocca W (2000) Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease. Mov Disord 15:819-825
12. Bower JH, Maraganore DM, McDonnell SK, Rocca WA (1999) Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 52:1214-1220
13. Hernán MA, Zhang SM, Rueda-deCastro AM, Colditz GA, Speizer FE, Ascherio A (2001) Cigarette smoking and the incidence of Parkinson's disease in two prospective studies. Ann Neurol 50:780-786
14. Grandinetti A, Morens DM, Reed D, MacEachern D (1994) Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 139: 1129-1138
15. Ascherio A, Zhang SM, Hernán MA, et al. (2001) Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 50:56-63
16. Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE (2003) Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology 60:790-795
17. Benedetti MD, Bower JH, Maraganore DM, et al. (2000) Smoking, alcohol, and coffee consumption preceding Parkinson's disease. Neurology 55:1350-1358
18. Corsini GU, Zuddas A, Bonuccelli U, Schinelli S, Kopin IJ (1987) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde. Life Sciences 40:827-832
19. Zuddas A, Corsini GU, Schinelli S, Johannessen JN, di Porzio U, Kopin IJ (1989) MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra. Brain Res 501:1-10
20. Carr LA, Rowell PP (1990) Attenuation of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity by tobacco smoke. Neuropharmacology 29:311-314
21. Ryan RE, Ross SA, Drago J, Loiacono RE (2001) Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha-4 nicotinic receptor subunit knockout mice. Br J Pharmacol 132:1650-1656
22. Castagnoli KP, Steyn SJ, Petzer JP, Van der Schyf CJ, Castagnoli N Jr. (2001) Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco. Chemical Res Toxicol 14:523-527
23. Chen J, Xu K, Petzer J, et al. (2001) Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 21:RC143